Invesaro

Stocks ANDE Financial statements

Financial statements

Andersons, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Andersons, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue3,9253,6863,0458,0038,06512,61217,32514,75011,25811,009
Cost of revenue3,5793,3682,7437,5427,69812,01916,64114,00510,56410,295
Gross profit346319302461366593684745694714
Operating expenses316287258437
Other non-operating income12.522.51618.518.237.433.850.542.278.3
Pre-tax income21.4-20.553.213-27.1161195170201141
Income tax6.91-63.111.99.15-10.929.239.63730.122.2
Income from continuing operations7.125.7599.711910111495.7
Net income to minority interests2.880.1-0.26-3.25-21.931.935.931.356.723.6
Net income11.642.541.518.37.7110413110111495.7
EPS, basic0.411.511.470.560.233.123.893.003.35
EPS, diluted0.411.501.460.550.233.073.812.943.32
Shares, basic (weighted)28.228.128.332.632.933.333.733.73434
Shares, diluted (weighted)28.428.328.533.133.233.934.434.434.334.3
Dividend per share0.630.650.670.690.700.710.730.750.770.79

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents62.634.922.654.929.121611564456298.3
Receivables1951832075366418351,249763765652
Inventory6836496911,1711,2931,8151,7321,1671,2871,365
Other current assets72.163.850.775.799.574.574.555.888.3125
Total current assets1,0589991,0231,9452,4163,3723,4662,8072,8502,376
Property, plant and equipment450385477938860786763693868940
Lease right-of-use assets076.433.452.161.954.2105109
Goodwill63.96.021.86131132129129128128128
Intangible assets10611399.117514011710185.669.363.5
Other non-current assets10.412.622.345.646.969.187.287101397
Total assets2,2332,1622,3923,9014,2724,5694,6083,8554,1213,713
Accrued liabilities69.669.679176153230246232227208
Deferred revenue134178358371187194195
Short-term debt47.554.222762.969.432.311027.636.163.4
Total current liabilities8007398331,4401,9322,4642,5211,6361,7311,686
Long-term debt3974184961,016886600493563608560
Lease liabilities051.119.831.337.131.765.371.5
Other non-current liabilities27.833.132.251.755.278.563.249.1117176
Total liabilities1,4421,3391,5152,7053,1113,2623,1782,3392,5212,423
Total debt4454735181,079956633493563608560
Paid-in capital223225224345349369385387386208
Retained earnings6096336486436267038088839711,039
Treasury stock-45.4-40.3-35.3-7.34-0.97-0.26-15-10.3-2.86-14.1
Other comprehensive income-12.5-2.7-6.39-7.23-12.11.1920.522.912.611.3
Shareholders' equity7748158309749621,0721,1991,2831,3661,245
Minority interests16.37.746.422219923523123323445.5
Total equity7918238771,1961,1611,3081,4301,5161,6001,290
Total liabilities and equity2,2332,1622,3923,9014,2724,5694,6083,8554,1213,713

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income14.542.641.215.1-14.2136167133171119
Depreciation and amortization84.386.490.3146189179135125128133
Stock-based compensation6.996.16.6216.210.21111.212.913.617
Deferred income tax6.03-63.2113.5625.80.2-17.5-1.96-3.37-8.66
Change in inventory28.216.1-44.1-1.58-139-52856.957287.9-72.4
Change in payables-94.7-5.62-69.9104123668230-564-102-144
Cash from operations39.675.3-35.5349-74.4-51.1287947332177
Capital expenditures-77.7-34.6-143-165-77.1-75.8-108-150-149-233
Acquisitions0-3.51-2.25-1030-11.4-20.2-24.7-29.20
Cash from investing-28.2-113-186-325-86.8487-52.9-154-163-195
Debt issued81.885.213292347220301006714.7
Debt repaid-97.6-57.2-121-608-560-531-30-49.6-83.6-36.2
Stock issued006.675.02
Share buybacks0000-12.7-1.75-2.3-15.4
Dividends paid-17.4-18.2-18.6-22.1-23-23.7-24.6-25.4-26.3-26.8
Cash from financing-12.510.52098.71136-249-335-264-250-447
Exchange rate effect000.07-0.88-0.11-0.66-0.29-0.161.98
Net change in cash-1.12-27.7-12.332.3-25.8187-101529-82.1-463
Free cash flow-38.240.7-178183-152-127179796182-56.1
Interest paid21.42429.643.433.938.256.74731.146
Income taxes paid-10.62.07-5.422.451.788.745.731.516.2

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $66.97 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin7.2%Gross profit / revenue.
Pre-tax margin2.0%Pre-tax income / revenue.
Net margin1.6%Net income / revenue.
FCF margin0.5%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin2.9%Cash from operations / revenue.
Effective tax rate15.9%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)13.4%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)5.1%Net income / average total assets.
Capex / revenue2.4%Capital expenditures / revenue.
D&A / revenue1.2%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y-2.2%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-14.0%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y6.4%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y2.8%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y1.4%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y14.3%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y-16.1%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y-10.0%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y65.5%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y-46.6%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y-14.9%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow growth, 1y-130.8%Free cash flow vs the same period a year earlier. Only from a positive base.
Dividend per share growth, 1y2.6%Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y2.7%Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y2.3%Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y-8.9%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y1.3%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y5.3%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y-9.9%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-6.9%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y-2.8%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y0.0%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-0.1%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y0.7%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.51xCurrent assets / current liabilities.
Quick ratio0.60x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.05x(Cash + short-term investments) / current liabilities.
Debt / equity0.44xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets16.9%Total debt / total assets.
Liabilities / assets60.9%Total liabilities / total assets.
Net debt$519.9MTotal debt - cash - short-term investments. Negative means more cash than debt.
Working capital$702.7MCurrent assets - current liabilities.
Tangible book value$1.32BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover3.15xRevenue / average total assets.
Fixed asset turnover11.2xRevenue / average property, plant and equipment.
Inventory turnover10.6xCost of revenue / average inventory.
Days inventory35 days365 x average inventory / cost of revenue.
Receivables turnover14.5xRevenue / average receivables.
Days sales outstanding25 days365 x average receivables / revenue.
FCF conversion32.1%Free cash flow / net income, when net income is positive.
Capex / operating cash flow82.3%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$5.17Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$319.18Revenue / diluted weighted shares.
FCF per share$1.66Free cash flow / diluted weighted shares.
Operating cash flow per share$9.39Cash from operations / diluted weighted shares.
Book value per share$38.48Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$38.48Tangible book value / shares outstanding.
Cash per share$1.94(Cash + short-term investments) / shares outstanding.
Payout ratio15.3%Dividends paid / net income, when net income is positive.
Dividends / FCF47.7%Dividends paid / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$2.28BShare price x shares outstanding.
Enterprise value$2.80BMarket cap + total debt - cash - short-term investments.
P/E12.8xMarket cap / net income. Only when net income is positive.
P/S0.21xMarket cap / revenue.
P/B1.73xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book1.73xMarket cap / tangible book value, when positive.
P/FCF40.0xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF7.07xMarket cap / cash from operations, when positive.
EV/Sales0.26xEnterprise value / revenue.
EV/FCF49.1xEnterprise value / free cash flow, when both are positive.
FCF yield2.5%Free cash flow / market cap.
Earnings yield7.8%Net income / market cap (the inverse of P/E).
Dividend yield1.2%Dividends paid over the period / market cap.
Shareholder yield1.2%(Dividends paid + share buybacks) / market cap.
What was Andersons, Inc.'s revenue in fiscal 2025?

Andersons, Inc. reported revenue of $11.01B for fiscal 2025, 2.2% lower than the year before.

Was Andersons, Inc. profitable in fiscal 2025?

Yes. Net income was $95.7M, a net margin of 0.9%.

How much free cash flow did Andersons, Inc. generate in fiscal 2025?

Cash from operations of $177.0M minus capital expenditures of $233.1M left free cash flow of -$56.1M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Andersons, Inc.